Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Enzyme Mutagenesis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN109456952B reveals a novel omega-transaminase mutant for Sitafloxacin intermediates. Discover cost-effective, scalable biocatalytic solutions for high-purity chiral amine production.
Patent CN112680425B reveals a novel alcohol dehydrogenase mutant for producing high-purity (S)-CHBE. This biocatalytic route offers significant cost reduction and supply chain reliability for statin manufacturing.
Patent CN108118035B reveals high-concentration enzymatic route reducing costs and improving purity for global supply chains.
Patent CN118480524A reveals a high-yield L-threonine transaldolase mutant for chloramphenicol intermediates, offering superior stereoselectivity and scalable green manufacturing solutions.
Patent CN115786313B reveals enhanced nitrilase mutant for 2-chloronicotinic acid. Delivers significant yield improvements and green manufacturing advantages for supply chains.
Patent CN111154746B reveals high-activity amidase mutants enabling green, scalable production of 2-chloronicotinic acid for agrochemical and pharmaceutical applications.
Novel S173Q/Q360Y mutant enzyme boosts D-alanine yield by 20% and stability 3-fold, offering cost-effective pharma intermediate solutions.
Patent CN108690836B details a mutated cyclohexanone monooxygenase for high-conversion esomeprazole synthesis, offering superior purity and scalability for API manufacturers.
Patent CN116574707B reveals high-activity LeuDH mutant for L-tert-leucine. Enables cost reduction in pharmaceutical intermediates manufacturing with high purity.